BlueRock Therapeutics LP is a clinical stage cell therapy company focused on developing new medicines for neurological and ophthalmic diseases. Our investigational cell therapies, bemdaneprocel (BRT-DA01) for Parkinson's disease and OpCT-001 for primary photoreceptor diseases, are in clinical stages. Founded in 2016, BlueRock is a joint venture of Versant Ventures and Leaps by Bayer. Our culture emphasizes courage, urgency, integrity, and community. We utilize foundational science to create and direct the differentiation of universal pluripotent stem cells into authentic, functional cells for allogeneic cellular therapies. We can also engineer these cells to produce therapeutic proteins. We are passionate about advancing cellular and gene therapy to shape the future of cellular medicine and deliver new therapies to millions of patients. We seek collaborative individuals who thrive in a dynamic culture and are committed to advancing cutting-edge cellular therapies. The Clinical Operations Study Lead (COSL)/Associate Director is responsible for the management and operations of one or more BlueRock clinical trials. This role serves as the accountable BlueRock leader for the operational planning, execution, and oversight of clinical studies. The COSL ensures studies are conducted in compliance with regulatory requirements and timelines, while promoting cross-functional collaboration and operational excellence.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level